|
KIAA1429 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.435800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.882850E-01 |
| Normal-vs-Stage2 |
9.181600E-01 |
| Normal-vs-Stage3 |
3.788400E-01 |
| Normal-vs-Stage4 |
3.262200E-01 |
| Stage1-vs-Stage2 |
2.753400E-01 |
| Stage1-vs-Stage3 |
1.997560E-02 |
| Stage1-vs-Stage4 |
2.385600E-02 |
| Stage2-vs-Stage3 |
5.570000E-01 |
| Stage2-vs-Stage4 |
4.755200E-01 |
| Stage3-vs-Stage4 |
8.748800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.867000E-01 |
| Normal-vs-AfricanAmerican |
1.100200E-02 |
| Normal-vs-Asian |
6.436200E-01 |
| Caucasian-vs-AfricanAmerican |
2.318800E-03 |
| Caucasian-vs-Asian |
5.954400E-01 |
| AfricanAmerican-vs-Asian |
2.677000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.996000E-01 |
| Normal-vs-Female |
7.851200E-01 |
| Male-vs-Female |
8.413400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.703800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.911200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.357600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.708440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.511400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.311800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.427600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.443200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.355010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.151400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.943970E-02 |
| Normal-vs-Grade 2 |
8.928500E-02 |
| Normal-vs-Grade 3 |
4.149000E-01 |
| Normal-vs-Grade 4 |
7.159700E-02 |
| Grade 1-vs-Grade 2 |
2.168200E-01 |
| Grade 1-vs-Grade 3 |
1.546440E-02 |
| Grade 1-vs-Grade 4 |
6.261100E-03 |
| Grade 2-vs-Grade 3 |
3.044400E-03 |
| Grade 2-vs-Grade 4 |
8.403400E-04 |
| Grade 3-vs-Grade 4 |
1.759420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.729700E-02 |
| Normal-vs-ccB subtype |
6.353400E-01 |
| ccA subtype-vs-ccB subtype |
1.738690E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.330000E-01 |
| Normal-vs-N1 |
6.674400E-01 |
| N0-vs-N1 |
6.744200E-01 |
|
|
